• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

From a molecule of natural origin new therapeutic opportunities against hypertension

Bioengineer by Bioengineer
December 31, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A peptide extracted from the cyanobacterium ‘spirulina’ may contrast high blood pressure by dilating blood vessels

Spirulina is more and more celebrated as a “superfood” because of its possible beneficial properties, albeit its mechanism of action is still subjected to investigation. With the scientific name of Arthrospira platensis, spirulina is a cyanobacterium, a bacterium capable of photosynthesis. Sometimes classified as a “blue algae”, it was supposedly used as a food by the Aztecs.

Now a research from the Vascular Physiopathology Laboratory of the I.R.C.C.S. Neuromed in Pozzilli (Italy) shows that one of its extracts may counteract arterial hypertension by dilating blood vessels.

Neuromed researchers, working in collaboration with University of Salerno, Sapienza University of Rome and Federico II University of Naples, isolated from the spirulina extract a peptide (a molecule composed of amino acids, such as proteins, but smaller) capable of dilating arteries, thus leading to antihypertensive action. The study, published in the journal Hypertension, was conducted both in the laboratory, on isolated arteries, and on animal models.

“Our research – says Albino Carrizzo, first author of the paper – started by conducting simulated gastrointestinal digestion on the raw extract of spirulina. In other words, we reproduced what happens in the human gut after ingesting the substance. This way we have been able to isolate the peptides that would be absorbed by our body “.

One of the isolated peptides, named SP6, has been identified for the first time. Administered to isolated blood vessels in the lab, it showed vasodilatory action, a potentially antihypertensive effect. This led researchers to administer SP6 to hypertensive animals, resulting in an effective lowering of blood pressure.

“We know – says Carmine Vecchione, Professor at the University of Salerno and head of Vascular Physiopathology Laboratory at Neuromed Institute – that hypertensive patients often have a defect in the natural processes that, by the action of nitric oxide, regulate endothelium (the inner wall of blood vessels). The peptide we isolated in spirulina extract acts positively on this mechanism. Of course, further researches will be necessary, but we think that SP6 could be a natural adjuvant to common pharmacological therapies in order to improve endothelial function and, consequently, combat hypertension”.

###

The I.R.C.C.S. Neuromed

The Institute for Research, Hospitalization and Health Care (I.R.C.C.S.) Neuromed in Pozzilli (Italy) is a landmark, at Italian and international level, for research and therapy in the field of nervous system diseases. A center in which doctors, researchers, staff and the patients themselves form an alliance aimed at ensuring the best level of service and cutting-edge treatments, guided by the most advanced scientific developments.

Media Contact
Americo Bonanni
[email protected]
39-347-930-5981

Tags: CardiologyMedicine/HealthNutrition/Nutrients
Share12Tweet8Share2ShareShareShare2

Related Posts

Blood Transfusions Increase Bronchopulmonary Dysplasia Risk in Preemies

September 10, 2025

New ECU Study Reveals Muscle Loss in Children During Early Cancer Treatment: A Hidden Threat to Recovery

September 10, 2025

Biochar and Starch Combo Boosts Lettuce Resilience Against Antibiotic Pollution

September 10, 2025

RSV Can Severely Impact Even Healthy Children, New Research Shows

September 10, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    52 shares
    Share 21 Tweet 13
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Global Movement and Annual Cycle in Spoonbills

Targeted Intraoperative Radiotherapy Advances in Early Breast Cancer

Blood Transfusions Increase Bronchopulmonary Dysplasia Risk in Preemies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.